Paper on cranberries’ health benefits retracted after researcher forges authors’ names

Image via Bruce Foster.
Image via Bruce Foster.

A paper in Food Chemistry suggesting cranberry extract has healing properties was retracted after some of the authors complained they had no idea the paper was being published.

Here’s the notice for “Phenolic composition, antioxidant properties, and endothelial cell function of red and white cranberry fruits:” Continue reading Paper on cranberries’ health benefits retracted after researcher forges authors’ names

Thalidomide paper retracted for lab error

fertstertResearchers at the University of Pittsburgh have retracted a paper on using thalidomide, which led to an estimated 10,000 birth defects by the time the drug was pulled from the market in 1961, to prevent chemo-induced sterility.

Alkylating agents, which prevent DNA replication in cells, are a commonly-used cancer treatment. Unfortunately they also damage the ovaries and testes, sometimes causing infertility. The University of Pittsburgh scientists published a paper in Elsevier journal Fertility and Sterility in 2011 that suggested thalidomide, which causes severe birth defects when used during pregnancy, might help protect ovaries during chemo.

However, according to the notice, the authors tried and failed to replicate their results. They had two separate scientists who were not authors take a look at the results; everyone agreed that the original study incorrectly reported the number of primordial follicles, the precursor to mature eggs.

Here’s the notice for “Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity”: Continue reading Thalidomide paper retracted for lab error

Can’t spell Novartis without VART: Drug study retracted for conflict of interest, data issues

JHH(Cover).inddA major scandal in Japan over the Novartis hypertension drug valsartan has resulted in a retraction from the Journal of Human Hypertension. 

Frequent Retraction Watch subject Hiroaki Matsubara resigned his post at Kyoto Prefectural University in 2013, after his work on valsartan was shown to be riddled with data errors and undisclosed conflicts of interest.

Also that year, suspicions about Chiba University hypertension researcher Issei Komuro’s work were first raised by an anonymous blog, which detailed numerous image manipulations in the researcher’s published works. Komuro, who frequently collaborated with Matsubara, has been a senior author on a number of valsartan papers, including the now-retracted one, which reported the results of Novartis-sponsored Valsartan Amlodipine Randomized Trial in 2011 without reporting the Novartis funding.

The paper, which has been cited three times, according to Thomson Scientific’s Web of Knowledge, had already been subject to a correction in 2013Continue reading Can’t spell Novartis without VART: Drug study retracted for conflict of interest, data issues

AIDS denialism paper retracted after Jeffrey Beall draws attention to it

scirpA paper arguing that HIV does not cause AIDS has been retracted a few weeks after Jeffrey Beall, who tracks predatory publishers, called attention to it on his blog.

Here’s what Beall wrote about the paper on December 16:

The article is entitled “Basic Principles Underlying Human Physiology[1], and you don’t have to be a scientist to know that it’s junk, for it is a manifestation of AIDS denialism. The conclusion’s first paragraph says,

HIV is not etiologically involved in AIDS. It is just a common retrovirus found in AIDS conjuncturally. There is only AIDS that may not be strictly associated neither to a primary immune deficiency nor to an acquired immune deficiency. Actually, heart failure represents the causal factor of AIDS and many other “primary” immune deficiencies (p. 1821).

Now, in that article’s place, this retraction, dated December 19, appears: Continue reading AIDS denialism paper retracted after Jeffrey Beall draws attention to it

Fake peer review fells two more papers

medicineThe number of papers retracted for fake peer reviews — well in excess of 100, by our count — continues to grow.

The latest to join the list are “Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials” and “Association study of TGFBR2 and miR-518 gene polymorphisms with age at natural menopause, premature ovarian failure and early menopause among Chinese Han women,” both published in 2014 in Medicine.

Here’s how both notices, signed by senior publisher Duncan A. MacRae, read: Continue reading Fake peer review fells two more papers

Second retraction appears for Mart Bax

ethnosRetired Dutch anthropologist Mart Bax made a career out of making up papers, many of them on the Bosnian genocide.

He retired from the Free University in Amsterdam in 2002. It wasn’t until 2013 that the university published a report indicating that Bax never published 61 of the papers he listed on his CV, and many of the real articles were based on fabricated data.

Publisher Taylor and Francis retracted one of Bax’s papers from Ethnic and Racial Studies in April. Now they’re retracting a second, from Ethnos, using almost identical language.

Here’s the notice: Continue reading Second retraction appears for Mart Bax

Nature Cell Biology insulin paper retracted over antibody problems

nature cell biologyNature Cell Biology article on insulin regulation has been retracted after scientists noted that the antibodies used in their research were not as specific as they had previously believed.

The notice is clear on the problems with the science, which together “call into question the main conclusions of the paper.” Three of the paper’s five authors were employed at Novartis at the time of publication.

Here’s the notice for “Wolfram syndrome 1 and adenylyl cyclase 8 interact at the plasma membrane to regulate insulin production and secretion”: Continue reading Nature Cell Biology insulin paper retracted over antibody problems

Paper recommending calorie limits on Happy Meals retracted

Image via Stefan

A paper estimating the effects of limiting fast food meals with toys to under 550 calories has been retracted after concerns arose regarding the scientists’ use of an outdated model for estimating weight changes in kids.

The paper estimated that kids who eat fast food twice a week would avoid gaining two pounds a year if calorie limits are imposed on meals with toys. However, everyone we spoke to, and the notice, indicated that their estimate was inaccurate.

Here’s the notice for “Modeling Potential Effects of Reduced Calories in Kids’ Meals with Toy Giveaways”:

Continue reading Paper recommending calorie limits on Happy Meals retracted

Paper that formed basis of study retracted earlier this year retracted itself, from Science

science dec 2014Back in May, we reported on a retraction from Molecular Cell that referred to a 2012 study the same group had published in Science. (A few weeks later, the lab head told us just how painful the process was.)

Now, the Science paper has been retracted. Here’s the notice: Continue reading Paper that formed basis of study retracted earlier this year retracted itself, from Science

Researchers retract paper for which first author won an award — but won’t sign notice

Bernasconi_Premio_Roche2012_small
Riccardo Bernasconi

Most of the authors of two Molecular Cell papers have retracted them after becoming aware of inappropriate image manipulation by the first author of both — who refused to sign the notices.

One of the papers, “Role of the SEL1L:LC3-I Complex as an ERAD Tuning Receptor in the Mammalian ER,” earned first author Riccardo Bernasconi, who successfully defended his PhD in 2010, the STSBC-Roche Diagnostics award in 2012. Here’s the notice for that paper: Continue reading Researchers retract paper for which first author won an award — but won’t sign notice